Endonovo Therapeutics Inc (ENDV)

[Craig305]

July 1, Endonovo will have a new Chief Medical Officer, Dr. Nevena Zubcevik.
She specializes in Lyme Disease and head trauma.

In the 10K of last year, ENDV mentioned their desire for studying Lyme Disease.

"We will seek to enter the CNS market via a HDE for the treatment of encephalopathy in Lyme disease patients. Our FDA-Cleared Electroceutical Therapy is currently prescribed by a group of physicians to reduce neuroinflammation. We will seek to gather data from approximately 10 to 15 patients to support a Humanitarian Device Exemption from the FDA to reduce neuroinflammation in Lyme disease patients."

Let's see if this will come to light under the new CMO.